CRISPR Therapeutics to Participate in the Guggenheim Healthcare Talks 2021 Oncology Day

NEXT STORY
Global Fluid Management Systems Market (2020 to 2025) – Single-Use Disposable Devices and Accessories Presents Opportunities
PREV STORY
Meridian Bioscience Reports Record Setting First Quarter Fiscal 2021 Operating Results and Raises Full Year Fiscal 2021 Guidance
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Cytovia Therapeutics, Inc appoints Dr. Wei Li as Chief Scientific Officer to accelerate the development of iPSC CAR-NK Cell Therapy for Cancer

author_avatar
NASDAQ Market News

Lundbeck announces retirement of Anders Gersel Pedersen, EVP and Head of Research and Development

Valby, Denmark, 4 December 2018 - H. Lundbeck A/S (Lundbeck) today announced that Anders ...

author_avatar
NASDAQ Market News

Insmed Announces Positive Top-Line Results from Phase 3 CONVERT Study of ALIS (Amikacin Liposome Inhalation Suspension) in Adult Patients with Treatment-Refractory Nontuberculous Mycobacterial (NTM) Lung Disease Caused by Mycobacterium Avium Complex (MAC)

Study met primary endpoint of culture conversion (p< 0.0001)Positive top-line results from global Phase ...

author_avatar
NASDAQ Market News